Expertise in
3
conditions

Sebastien Gibot

Nancy, FR 
Expertise in
3
conditions
Nancy, FR 

Overview

Sebastien Gibot practices practicing medicine in Nancy, France.

Mr. Gibot is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Sepsis, Acute Respiratory Distress Syndrome (ARDS), Pneumonia, and Secondary Peritonitis.

He is actively involved in clinical research, co-authoring 106 peer reviewed articles and participating in 4 clinical trials.

Gender

Male

Locations

Nancy, France
Other Locations
Limoges, France
Vandoeuvre-les-nancy, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Multi-centre, Adaptive, Randomized Trial of the Safety and Efficacy of Treatments of COVID-19 in Hospitalized Adults
Multi-centre, Adaptive, Randomized Trial of the Safety and Efficacy of Treatments of COVID-19 in Hospitalized Adults
Enrollment Status: Completed
Publish Date: July 08, 2026
Intervention Type: Other, Drug
Study Drugs: Remdesivir, Lopinavir, Ritonavir, Interferon Beta-1A, Hydroxychloroquine, AZD7442
Study Phase: Phase 3
Effects of Low-dose Corticosteroids on Survival of Severe Community-acquired Pneumonia
Effects of Low-dose Corticosteroids on Survival of Severe Community-acquired Pneumonia
Enrollment Status: Completed
Publish Date: December 22, 2025
Intervention Type: Drug
Study Drug: Hydrocortisone
Study Phase: Phase 3
Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Study of AB103 as Compared to Placebo in Patients With Necrotizing Soft Tissue Infections. ACCUTE (AB103 Clinical Composite Endpoint Study in Necrotizing Soft Tissue Infections)
Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Study of AB103 as Compared to Placebo in Patients With Necrotizing Soft Tissue Infections. ACCUTE (AB103 Clinical Composite Endpoint Study in Necrotizing Soft Tissue Infections)
Enrollment Status: Completed
Publish Date: October 05, 2021
Intervention Type: Other, Drug
Study Phase: Phase 3
Prediction of Acute Heart or Kidney Injury With Cardiovascular-renal Biomarkers in Patients Hospitalised for Severe or Critical Covid-19 Infection
Prediction of Acute Heart or Kidney Injury With Cardiovascular-renal Biomarkers in Patients Hospitalised for Severe or Critical Covid-19 Infection
Enrollment Status: Completed
Publish Date: October 01, 2021
Intervention Type: Procedure
Study Phase: Not Applicable
View 3 Less Clinical Trials

106 Total Publications

A high level of sTREM-1 predicts occurrence of thrombosis, obstetrical event or death in a prospective cohort of patients with antiphospholipid antibodies and/or systemic lupus. Results of the APLART study.
A high level of sTREM-1 predicts occurrence of thrombosis, obstetrical event or death in a prospective cohort of patients with antiphospholipid antibodies and/or systemic lupus. Results of the APLART study.
Journal: Lupus
Published: November 14, 2025

Frequently Asked Questions about Sebastien Gibot

Is Sebastien Gibot a top-rated expert for Sepsis?

MediFind is an objective health platform that identifies experts based on real-world data. Sebastien Gibot is classified as an Advanced expert for Sepsis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Sebastien Gibot participate in research or clinical trials?

Yes. Sebastien Gibot has published 106 articles and abstracts on conditions like Sepsis. You can view a list of Sebastien Gibot's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Gibot's expertise for a condition
ConditionClose
      View All 15 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile